NICOLE HARTMAN: Open Payments
NPI 1518437615 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,068 in 48 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $410 · 2025 $1,068
Food & beverage: $1,068
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 8 | $198 |
| ABBVIE INC. | 8 | $143 |
| Amgen Inc. | 2 | $118 |
| Novo Nordisk Inc | 5 | $106 |
| PFIZER INC. | 3 | $71 |
| Exact Sciences Corporation | 2 | $51 |
| AstraZeneca Pharmaceuticals LP | 3 | $49 |
| Sumitomo Pharma America, Inc. | 3 | $48 |
| Inspire Medical Systems, Inc. | 2 | $42 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $42 |
Products named: EVENITY, UBRELVY, Cologuard Collection Kit, NURTEC ODT, GEMTESA, INSPIRE, XIFAXAN, QULIPTA.
Industry payments across PA — which companies pay providers there.
